WEC
AVEO

Winslow Evans & Crocker’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Winslow Evans & Crocker’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-45
Closed -$2K – 1364
2018
Q4 		$2K Hold
45
– – ﹤0.01% 1082
2018
Q3 		$2K Hold
45
– – ﹤0.01% 1093
2018
Q2 		$2K Buy
+45
New +$1.07K ﹤0.01% 1106

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Winslow Evans & Crocker's AVEO Position: Q1 2019 in Review

Winslow Evans & Crocker sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 45 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in AVEO in Q2 2018 and held it in 3 quarters. The position peaked at $2K in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • Winslow Evans & Crocker reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 45 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $2K.
  • Winslow Evans & Crocker first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
  • Winslow Evans & Crocker's AVEO Pharmaceuticals, Inc. position peaked at $2K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Winslow Evans & Crocker's 13F filing for Q1 2019, filed 22 Apr 2019.